Médecins du Monde
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Early Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (50.0%)Not Applicable
1 (50.0%)Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Not yet recruiting
- Conditions
- HepatitisDrug UseHiv
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Médecins du Monde
- Target Recruit Count
- 2400
- Registration Number
- NCT06395129
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
Early Phase 1
Recruiting
- Conditions
- Hepatitis CRDT
- Interventions
- Drug: sofosbuvir/velpatasvir (SOF/VEL)Diagnostic Test: Shortened read time of rapid diagnostic test for hepatitis C virus.
- First Posted Date
- 2023-12-06
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Médecins du Monde
- Target Recruit Count
- 3040
- Registration Number
- NCT06159504
- Locations
- 🇦🇲
National Institute for Infectious Diseases, Yerevan, Armenia
Improving Access to Cervical Cancer Screening
Not Applicable
- Conditions
- Uterine Cervical Neoplasms
- First Posted Date
- 2017-04-18
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Médecins du Monde
- Target Recruit Count
- 1258
- Registration Number
- NCT03118258
- Locations
- 🇫🇷
Médecins du Monde, Paris, Ile De France, France
News
No news found